Information updates

ASCIA Immunodeficiency Strategy for Australia and New Zealand

6 November 2020

It is a pleasure to announce that the ASCIA Immunodeficiency Strategy for Australia and New Zealand has now been completed and is available at www.nationalimmunodeficiencystrategy.org.au

Over the past two years ASCIA has worked in collaboration with patient organisations (AusPIPs Inc, HAE Australasia, IDFA, IDFNZ) and other stakeholders to develop the first Immunodeficiency Strategy at a national level for both Australia and New Zealand. The Mission of the Strategy is to improve the health and wellbeing of people living with primary immunodeficiencies (PIDs) and minimise the burden on individuals, carers, health services and the community.

The Strategy was completed in time for it to be lodged as an attachment to the ASCIA submission in response to the Parliamentary Inquiry into approval processes for new drugs and novel medical technologies in Australia. The ASCIA submission was lodged by the extended deadline of Tuesday 3 November 2020 and is available at www.allergy.org.au/ascia-reports#s1

The ASCIA Immunodeficiency Strategy content is not influenced by the support received via unrestricted educational grants from CSL Behring (2019 and 2020), and Grifols (2019), which enabled ASCIA to develop the Strategy document. 

ASCIA looks forward to working in collaboration with patient organisations, other stakeholders and governments to implement the ASCIA Immunodeficiency Strategy for Australia and New Zealand Strategy from 2021 onwards. It is ASCIA’s intention is to host an official launch and implementation meeting early next year (as a hybrid meeting), subject to further funding. A timeline and strategic action plan for implementation will depend on funding and agreement regarding priorities.

 

Mod ASCIA Member
Donate to AIFA
go to NAS website
Member Login
ASCIA Update

Information for the community about allergic diseases, immunodeficiencies and other immune diseases.
See latest edition here...
Join our mailing list:

About ASCIA

ASCIA is the peak professional body of clinical immunology and allergy in Australia and New Zealand
ASCIA promotes and advances the study and knowledge of allergy and other immune diseases

Quick Links

About ASCIA

ASCIA is a registered trademark of the Australasian Society of Clinical Immunology and Allergy. All content is subject to copyright for the Australasian Society of Clinical Immunology and Allergy. Read more...

The content for the website is developed and approved by ASCIA Committee and ASCIA Working Party Members. Read more...

Disclaimer I Privacy

The ASCIA website is intended for use by ASCIA members, health professionals and the general public. The content provided is for education, communication and information purposes only and is not intended to replace or constitute medical advice or treatments. Read more...

ASCIA respects your privacy. Read our privacy policy here...

Sponsors | Advertising

ASCIA does not endorse products from sponsoring organisations, nor is it influenced by sponsoring organisations with regard to the content of education programs and websites. 

The ASCIA website does not accept advertising. Any link to a third-party website does not imply any endorsement by ASCIA.

Accreditiation

healthdirect

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information: verify here.